ASTCT Review of Key Proposed Changes in FY2021 IPPS for CAR-T and Allogeneic HCT

This webinar aired on May 19, 2020. Topics covered in this webinar include:

    A breakdown of what CMS has proposed
    New CAR-T MS-DRG 018
    Elimination of NTAP
    Impact of adjustments and outlier policy
    Proposed payment method for CAR-T clinical trial cases
    Overview of the reasonable cost reimbursement methodology for reimbursement of allogeneic stem cell transplants
    Round up of other major proposed changes
    Initial feedback/thoughts about advocacy implications

The speakers will also walk through a two-hospital CAR-T reimbursement scenario to give hospitals a feel for the financial impact of CMS’ proposals relative to today’s payment.